BioAgilytix and ATCC Present the First ‘Trends in Cell-Based Assays’ Forum

The first ‘Trends in Cell-Based Assays’ forum was held this week in Cambridge, hosted by ATCC and BioAgilytix, who partnered with Shire Pharmaceuticals, Takeda Pharmaceuticals, Visterra and the former senior advisor of Science Innovation and Policy for the FDA.

Click for full article

Featured Expert

Pharmacokinetics & Pharmacodynamics​

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.
220328 Adleverage_Scientific Icon Illustrations_#46-65_CO_Per FIles